TRX Gold Down 60%: Strong Operations but Expansion Risk Remains

What happened

TRX Gold shares have fallen approximately 60% from their January 2026 highs, as market fears over execution risk and gold price sensitivity have overshadowed strong operational performance. The company reported robust Q1 FY2026 results with record production of 6,597 ounces poured, revenue of $25.1M, and EBITDA of $13.2M, driven by a realized gold price of $3,860/oz. Despite this cash generation, the stock's decline reflects investor skepticism about the company's ability to self-fund its Track 1 and Track 2 processing plant expansions without equity dilution. Upcoming catalysts include a Q4 2026 PEA update expected to show higher plant capacity and improved recoveries, which could refocus attention on the expansion's potential value. However, the deepvalue analysis maintains a WAIT rating until the company demonstrates consistent internal funding of capex and delivers on milestone promises, as the current valuation still implies significant execution success.

Implication

The 60% pullback has brought TRX closer to its bear-case valuation of $1.00, but the stock still trades at elevated multiples (24x EV/EBITDA) relative to the risk of a single-asset producer undergoing a capex program. The bull case relies on sustained high gold prices and flawless execution of the expansion plan without dilution. The deepvalue report's key triggers remain: watch for Track 1 upgrades completion on time, operating cash flow covering capex, and no equity issuance. Given the sell-off, the risk/reward has improved, but the thesis delta is minimal until financial proof emerges. Investors should monitor the Q2 FY2026 results for working capital recapitalization and the Q4 PEA update for NPV validation.

Thesis delta

The core thesis remains unchanged—TRX is a high-risk, high-reward bet on self-funded expansion. However, the 60% sell-off has increased the potential upside if execution succeeds, but also raises the stakes: any miss on guidance or funding plan could push the stock to $1.00. The wait-for-proof stance is reinforced, as the market's fear may be overdone but is not unfounded.